In the News

The Biggest Patent Rulings Of 2021, Law360

December 13, 2021

Partner Michael Abernathy spoke to Law360 about one of the biggest patent rulings of the year, Juno Therapeutics Inc. et al. v. Kite Pharma Inc. The ruling—which reversed a $1.1 billion judgment against Gilead’s Kite Pharma Inc. for infringing Bristol-Myers’ cancer immunotherapy patent for the drug Yescarta—concluded that the patent is invalid because it lacks adequate written description support. This could encourage more challenges to antibody patents, Mike observed. “As a litigator in this field, I now look at life and say, ‘Antibody claims will certainly be attacked more frequently in litigation.’”

Read the full Law360 article >>